Allows Formulary Committee members with potential conflicts of interest to participate in communications and discussions.

The bill permits members of the Formulary Committee to engage in communications and discussions despite potential conflicts of interest. It requires the commissioner of human services to develop a public comment process for Formulary Committee recommendations, mandates the committee to seek expertise from the Minnesota Rare Disease Advisory Council, and outlines the committee's composition and duties. The committee includes licensed physicians, pharmacists, and consumer representatives, and it meets at least three times per year.

Allows Formulary Committee members with potential conflicts of interest to participate in communications and discussions.

The bill permits members of the Formulary Committee to engage in communications and discussions despite potential conflicts of interest. It requires the commissioner of human services to develop a public comment process for Formulary Committee recommendations, mandates the committee to seek expertise from the Minnesota Rare Disease Advisory Council, and outlines the committee's composition and duties. The committee includes licensed physicians, pharmacists, and consumer representatives, and it meets at least three times per year.